Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

 

 

Word Count

Abstract

Introduction

Materials & Methods/ Case Description

Results

Conclusion

Discussion

References

Research

2500-4500

30-50

Brief Report

2500

30

Review

2500-7000

 

 

50-100

Mini Review

2500

 

 

50-75

Case Report

1500

 

25

Short/Brief Communication

1200

 

 

 

 

 

25

Commentary

1000

 

 

 

 

 

 

20

Clinical Images

100

 

 

 

 

 

10

Letter to Editor

1000

 

 

 

 

 

 

10

Editorial

1000

 

 

 

 

 

 

10

We encourage authors to submit the original work with appropriate results and citations by adhering to the best publication practices stated by scholarly organizations - COPE, WAME, DOAJ

Under few conditions, authors should be ready to submit original raw data along with the manuscript for the review process without any concert. Same research content or information should not be published in more than one journal or publishing house.

Authors are responsible for the content or information in the manuscript. The corresponding author needs to include all coauthors and acknowledgment with the written consent. Authors need to disclose any conflict of interest that interprets the results or content in the manuscript. All the resources and sources of financial grant for the research work need to disclose.

The author's research involved chemical procedures, hazards are to be mentioned in the manuscript. Any animal or human experiments should be under the guidelines and approval of appropriate committees. The rights of the human participants must always be considered along with a consent letter.

All Authors cooperate for speedy publishing process like peer review process and submit the required data, clarifications, ethics approval proofs, copyright permission, participant or patient consent.

If required based on peer review comments author needs to revise the manuscript by considering the review comments for maintaining the quality of the manuscript.

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file (word doc); figures, tables, images. Tables and figures along with their respective legends at the end of the manuscript. Figures should be of high resolution, the content of the figures and tables should be clear and legible.


Main Text File

The text file should be presented in the following order:

i. A short informative title containing the major keywords. The title should not contain abbreviations
ii. A short running title of less than 50 characters;
iii. The full names of the authors (* corresponding author name);
iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
v. Acknowledgments;
vi. Abstract and keywords;
vii. Main text;
viii. References;
ix. Tables (each table complete with title and footnotes);
x. Figure legends;
xi. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.


Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process.

Manuscript Preparation

The first letter of each word in the title should be upper case.

Include article title, author's names (complete names), affiliations, corresponding author's phone/fax number and/or email, and full postal address.

The abstract should not contain citations to references.

Don’t include citations to references in the abstract and should not exceed 300 words

Make sure to provide 3-6 keywords (MeSH terms).

The recommended structure of the introduction:

Background of the subject

What is known and unknown about it

Hypothesis

Aim of the study

Materials and methods

Ethics approval/license:

The study involving animal or human investigations should abide by the ethical norms stated in the Declaration of Helsinki, and adopted in October 2000 by the World Medical Association. This document can be found at http://www.wma.net/en/30publications/10policies/b3/.

The study should be approved by the appropriate ethical committee. Written informed consent of the population involved in the study or that the requirement for written informed consent was waived by the ethics committee.

Patient/Animal data: Data of animals or patients should be presented which includes Human – mean age (range), sex, weight, height, etc. Animals – strain, sex, weight. Should seek the necessary permission from the patients for the type of study being undertaken.

Inclusion/exclusion criteria

Data handling: Information of the clinical trials, research using animals - institutional approval, anaesthesia methodology, Euthanasia process, etc should be explained.

Statistics: the statistical analysis used in the study should be explained in detail. The results obtained should be quantified and presented with appropriate indicators of measurement error or uncertainty.

Results: This section should include

Factual information

Should correlate with the aim

Logical order

State significance

Negative findings

Discussion: This is a very important section of the paper as this gives the complete information of the paper. Therefore, this section should include:

Information on main findings: It should provide a concise overview of the study. How they fit in with previous studies: Should relate directly to the statements made in the Introduction and qualify your finding in connection to the previous studies of the subject.

Difference between the present and previous studies: The author should explain the important difference between the present study in comparison with the previous studies.

What knowledge it adds to the subject: The author can summarize the previous sections by pulling together the implications of your main findings, studies by other workers, and their combined contribution to our knowledge of the subject.

Limitations in the present study: The author should clearly state the limitation of the study leaving scope for further study.

Conclusion: Very important of the paper. This should include information on the contribution of the information or knowledge from the present study to the field.

Acknowledgment: One may acknowledge the contribution of others or data providers or clinical investigators etc who do not qualify for authorship.

Declaration of Interest: Each manuscript must contain a declaration of interest from all authors. The corresponding author on behalf of all authors should confirm that there is no conflict of interest.

Funding Details: Complete information of the funding towards the work should be reported.

References: the format is stated in detail. The journal follows Vancouver style.

Tables and Figures: Tables and Figures are an easy and important way of communicating the study. Therefore, the information of these should be clear and legible.

References Format

Standard journal article --- Arial 11.5

Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.

List the first six authors, followed by et al. If there are more than six authors, list the first six authors, followed by et al. (Note: NLM now lists all authors.):

Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

Addition of a clinical trial registration number:

Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in compomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registration number: NCT00065988.

Organization as Author

Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.

Both personal authors and organization as author (List all as they appear in the byline.)

Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257-61.

Article not in English

Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen. 2002;122(8):785-7. Norwegian.

Volume with supplement

Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.

Issue with supplement

Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6-12.

Volume with part

Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002;83(Pt 2):491-5.

Issue with part

Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.

Issue with no volume

Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230-8.

No volume or issue

Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1-6.

Pagination in roman numerals

Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002;16(2):iii-v.

Type of article indicated as needed

Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy [letter]. Eur Respir J. 2002;20(1):242.

Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002;66 Suppl 1:S105.

Article containing retraction

Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2002;63(2):169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2000;61(12):909-11.

Article containing a partial retraction:

Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction after removal of eroded slings. J Urol. 2006 Dec;176(6 Pt 1):2749. Partial retraction of: Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Sep;176(3):1040-4.

Article retracted

Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000;61(12):909-11. Retraction in: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2002;63(2):169.

Article partially retracted:

Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction following removal of eroded synthetic mid-urethral slings. J Urol. 2006 Sep;176(3):1040-4. Partial retraction in: Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Dec;176(6 Pt 1):2749.

Article republished with corrections

Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol. 2002;188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001;183(1-2):123-6.

Article with published erratum

Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther. 2000;22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther. 2001;23(2):309.

Article published electronically ahead of the print version

Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15;100(10):3828-31. Epub 2002 Jul 5.

Another important consideration for manuscript preparation

Grammar and spell check

All the references mentioned should be cited in the body/text

Permission has to be obtained for use of copyrighted material.

Suggest reviewers: contact details like professional mail id, phone number of the referred reviewer should be provided.

Information for Authors

Article Processing Charges:

Articles published in this journal are open access and made available freely immediately after publication. Therefore, to cover the charges of publishing services like article production, hosting, indexing, customer service are covered by Article processing charges. APC is payable by author, funder, institution, organization, or employer only when the manuscript is accepted by the editor.

At every stage of the article, processing involves the cost i.e administering the reviewers to hosting the article; authors are asked to pay these charges.

The article processing charge for this journal is 575GBP. There are no submission charges, so the ability to pay does not affect the editorial decisions. These APC will be under review regularly and are subject to change. This depends on many factors like Journal quality, the Journal’s editorial and technical process, market conditions, resources.

Articles

Section default policy

Review Article

default

Short Communication

default

Editorial

default

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.